Clinical Trial Update: Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™ [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating carotid artery revascularization using the Boston Scientific EPI Filter Wire EZ and the EndoTex NexStent has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• EPI Filter Wire EZ
• EndoTex NexStent

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Transient Ischemic Attack, Thromboembolic Stroke | Phase 3 | Status: COMPLETED